
3
Ultrasound Gel
Ultrasound gel (Figure 5) is provided for use with
EXOGEN. The gel is to be placed on the trans-
ducer every time you use EXOGEN. The gel lets
the ultrasound signal reach your fracture through
your skin. EXOGEN will not work properly if gel is
not covering the transducer and you will receive
an alert from EXOGEN.
Only use the gel supplied. Do not use other gels
as they may damage the transducer surface or
block the signal. If you need more gel, please
call Customer Service at 1-800-836-4080.
The expiration date for the ultrasound gel is
located on the side of the gel bottle.
Note: Some patients have experienced mild skin
irritation caused by skin sensitivity to the gel. If
you feel your skin is sensitive to the gel, you may
change the gel to mineral oil or glycerin.
Important Things to Know
EXOGEN is approved for use by persons that are
18 years or older and skeletally mature. There is
no maximum age limit to using EXOGEN. The
anticipated education level of an EXOGEN user
is to read English at an 8th Grade level or
equivalent, and the ability to read and understand
Western Arabic numerals. No special previous
experience or skills are needed or expected to be
able to operate EXOGEN. There may be physical
impairments that result from the presence of a
fracture, such as reduced range of motion or
immobility. EXOGEN is expected to be used
with one hand for guiding and holding EXOGEN.
Read “Getting Started” (page 5) and “Treating
Your Fracture” (page 10) before you begin using
EXOGEN.
EXOGEN Usage
EXOGEN should be used for 20 minutes per day
or as prescribed by your doctor. It is important
that you use EXOGEN as prescribed by your
doctor to get the full benet of the treatment. Your
doctor will decide when your fracture is healed.
Every fracture is different and it takes some
fractures longer to heal than others. Call your
doctor if you have questions or concerns about
your fracture.
EXOGEN is for single patient use only. EXOGEN
will deliver 343 full 20-minute treatments. If this
number is reached and you are still treating your
fracture under your doctor’s direction, contact
Customer Service at 1-800-836-4080 for
instructions.
Contraindications
There are no known contraindications to the use
of EXOGEN.
Warnings
The safety and effectiveness of the use of
EXOGEN has not been established for:
• Fractures with post-reduction displacement of
more than 50% (i.e., fractures in which the
opposing broken bone ends are out of alignment
by more than one half of the width of the bone)
• Pathological fractures due to bone pathology or
malignancy (fractures due to disease)
• Pregnant or nursing women
• Individuals with thrombophlebitis (blood clot in a
vein), vascular insufciency (poor blood supply),
abnormal skin sensitivity (very sensitive skin),
sensory paralysis (lack of sensation), alcoholism
and/or nutritional deciency
• Individuals receiving steroid, anticoagulant,
prescription non-steroidal anti-inammatory,
calcium channel blocker and/or diphosphonate
therapy. Individuals using these therapies were
excluded from the studies because of the possible
effects of these therapies on bone metabolism
• Non-unions of the vertebra and the skull
• Individuals lacking skeletal maturity
• Fresh fracture locations other than the distal radius
(end of the large bone in the forearm) or tibial
diaphysis (middle 80% of the large bone in your
lower leg)
• Fresh fractures that are open Grade II or III
(fractures with large wounds) or that require
surgical intervention with internal or external
xation (screws and/or plates used to hold your
broken bones in place) or that are not sufciently
stable for closed reduction (manipulation of the
fracture without surgery) and cast immobilization
(cast treatment)
Precautions
• EXOGEN will not correct or alter post-reduction
(when your fracture is initially set and placed in a
cast) aspects of a fracture such as displacement,
angulation or malalignment
• The transducer, strap and gel are not sterile and
placement on an open wound is not advised
• The operation of active, implantable devices, such
as cardiac pacemakers may be adversely affected
by close exposure to EXOGEN. The physician
should advise the patient or other person in close
proximity during treatment to be evaluated by the
attending cardiologist or physician before starting
treatment with EXOGEN
• The cords pose a risk for strangulation. Keep out
of reach of children
Figure 5 – Ultrasound Gel (Part Number: 71034694)
Cap
Nozzle
Bottle
Labeling LBL-000319 [D] RELEASED